rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
24
|
pubmed:dateCreated |
2008-12-16
|
pubmed:abstractText |
The progression of cardiac amyloidosis is a prognostic factor after liver transplantation (LT) in familial amyloid polyneuropathy (FAP). The aim of this study was to assess myocardial changes in FAP amyloidgenic transthyretin (ATTR) Val30Met after LT.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1349-7235
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
47
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2133-7
|
pubmed:meshHeading |
pubmed-meshheading:19075538-Adult,
pubmed-meshheading:19075538-Aged,
pubmed-meshheading:19075538-Amyloid Neuropathies, Familial,
pubmed-meshheading:19075538-Amyloidosis,
pubmed-meshheading:19075538-Biological Markers,
pubmed-meshheading:19075538-Cardiomyopathies,
pubmed-meshheading:19075538-Female,
pubmed-meshheading:19075538-Humans,
pubmed-meshheading:19075538-Liver Transplantation,
pubmed-meshheading:19075538-Male,
pubmed-meshheading:19075538-Middle Aged,
pubmed-meshheading:19075538-Natriuretic Peptide, Brain
|
pubmed:year |
2008
|
pubmed:articleTitle |
Evaluation of myocardial changes in familial amyloid polyneuropathy after liver transplantation.
|
pubmed:affiliation |
Department of Neurology, Graduate School of Medical Sciences, Kumamoto University, Honjo.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Evaluation Studies
|